155 related articles for article (PubMed ID: 38485866)
61. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
[TBL] [Abstract][Full Text] [Related]
62. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
[TBL] [Abstract][Full Text] [Related]
63. Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas.
Otsuka T; Morizane C; Nara S; Ueno H; Kondo S; Shimada K; Kosuge T; Ikeda M; Hiraoka N; Okusaka T
Pancreas; 2013 Jul; 42(5):889-92. PubMed ID: 23695798
[TBL] [Abstract][Full Text] [Related]
64. [I. The Efficacy of Preoperative Adjuvant Treatment for Pancreatic Ductal Adenocarcinoma Based on the Resectability Criteria according to JPS 7th].
Shinkai T; Kato H; Hayasaki A; Murata Y; Kishiwada M; Isaji S
Gan To Kagaku Ryoho; 2017 Oct; 44(10):837-844. PubMed ID: 29066676
[No Abstract] [Full Text] [Related]
65. Uncinatectomy: a novel surgical option for the management of intraductal papillary mucinous tumors of the pancreas.
Sharma MS; Brams DM; Birkett DH; Munson JL
Dig Surg; 2006; 23(1-2):121-4. PubMed ID: 16804308
[TBL] [Abstract][Full Text] [Related]
66. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: the conservative approach.
Fernandez-del Castillo C
J Gastrointest Surg; 2002; 6(5):660-1. PubMed ID: 12399052
[No Abstract] [Full Text] [Related]
67. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor.
Kim SY; Lee JM; Kim SH; Shin KS; Kim YJ; An SK; Han CJ; Han JK; Choi BI
AJR Am J Roentgenol; 2006 Nov; 187(5):1192-8. PubMed ID: 17056905
[TBL] [Abstract][Full Text] [Related]
68. Identification of high-risk features in mucinous cystic neoplasms of the pancreas.
Servin-Rojas M; Fong ZV; Fernandez-Del Castillo C; Ferrone CR; Rocha-Castellanos DM; Roldan J; Zelga PJ; Warshaw AL; Lillemoe KD; Qadan M
Surgery; 2023 May; 173(5):1270-1274. PubMed ID: 36822873
[TBL] [Abstract][Full Text] [Related]
69. The Deception of Pancreas Cyst Surveillance: A Case Study.
Lorenzo A; Hillel L
Gastroenterol Nurs; 2024 Jan-Feb 01; 47(1):27-32. PubMed ID: 38096043
[TBL] [Abstract][Full Text] [Related]
70. Adenocarcinoma with intraductal papillary mucinous neoplasm arising in a duodenal heterotopic pancreas: a case report.
Hisanaga E; Sano T; Kubo N; Ishii N; Shirabe K; Takagi H; Hirato J; Ikota H
Clin J Gastroenterol; 2020 Dec; 13(6):1373-1382. PubMed ID: 32909157
[TBL] [Abstract][Full Text] [Related]
71. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
[TBL] [Abstract][Full Text] [Related]
72. Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy.
Domínguez-Rosado I; Meléndez-Zajgla J
Rev Invest Clin; 2020 Dec; 72(6):333-336. PubMed ID: 33057318
[TBL] [Abstract][Full Text] [Related]
73. A case of intraductal papillary neoplasm of the bile duct accompanied by intraductal papillary mucinous neoplasm of the pancreas and hepatocellular carcinoma.
Kitahama T; Yamane H; Mohri K; Fukuoka E; Yoshida T; Yamagishi T; Goto H; Furutani A; Otsubo D; Matsumoto T; Tanaka M; Fujino Y; Tominaga M
Clin J Gastroenterol; 2021 Oct; 14(5):1536-1543. PubMed ID: 34106396
[TBL] [Abstract][Full Text] [Related]
74. [The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy].
Imamura T; Ikoma H; Morimura R; Hatakeyama T; Kosuga T; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2379-81. PubMed ID: 26805370
[TBL] [Abstract][Full Text] [Related]
75. [Chronic pancreatitis with pseudocysts?].
Veits L; Vieth M; Agaimy A
Pathologe; 2013 May; 34(3):272-5. PubMed ID: 23380876
[TBL] [Abstract][Full Text] [Related]
76. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: the aggressive approach.
Traverso LW
J Gastrointest Surg; 2002; 6(5):662-3. PubMed ID: 12399053
[No Abstract] [Full Text] [Related]
77. The balance: comment on "fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm".
Zenilman ME
Arch Surg; 2012 Jun; 147(6):534-5. PubMed ID: 22786538
[No Abstract] [Full Text] [Related]
78. Intraductal papillary mucinous neoplasm of the pancreas in an adult patient with cystic fibrosis after double-lung transplantation.
Eigner W; Mesteri I; Tribl B; Ba-Ssalamah A; Friedl J; Trauner M; Kazemi-Shirazi L
J Cyst Fibros; 2015 Jul; 14(4):523-5. PubMed ID: 25866146
[TBL] [Abstract][Full Text] [Related]
79. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Tanaka M; Chari S; Adsay V; Fernandez-del Castillo C; Falconi M; Shimizu M; Yamaguchi K; Yamao K; Matsuno S;
Pancreatology; 2006; 6(1-2):17-32. PubMed ID: 16327281
[TBL] [Abstract][Full Text] [Related]
80. Seminars in surgical oncology-Pancreas cancer adjuvant therapy trials.
Essaji Y; Rocha FG
J Surg Oncol; 2021 May; 123(6):1467-1474. PubMed ID: 33831255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
